Cardiovascular risk in chronic renal disease and transplantation prevention and management

Author： Malyszko Jolanta   Malyszko Jacek S   Bachorzewska-Gajewska Hanna  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.6, 2005-06, pp. : 929-943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Management for the Prevention of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular risk factors in progressive renal disease

By Harris KPG  

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 191-194

Royal College Of Physicians

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease

By Sin Don D   Man S.F P.  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 8-13

NRC Research Press

Access to resources Recommend Favorite

Asymmetric Dimethylarginine: a Novel Cardiovascular Risk Factor in End-stage Renal Disease

By Alsagaff M Yusuf   Thaha M   Aminuddin M   Yogiarto RM   Yogiantoro M   Tomino Y  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 340-349

Field House Publishing

Access to resources Recommend Favorite

Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: A Possible Role of Leptin

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 666-674

Bentham Science Publishers

Access to resources Recommend Favorite